YILDIRIM ŞİMŞİR I, SOYALTIN UE, SARER YÜREKLİ B, ERDOĞAN M, ÇETİNKALP Ş, SAYGILI F, DÖNMEZ A, ÖZGEN AG. Therapeutic plasma exchange in hypertriglyceridemic patients.
Turk J Med Sci 2019;
49:872-878. [PMID:
31203594 PMCID:
PMC7018319 DOI:
10.3906/sag-1811-105]
[Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
Background/aim
High triglyceride (TG) levels are associated with increases in atherosclerotic cardiovascular disease (CVD), hepatic steatosis, and pancreatitis. Acute pancreatitis is a condition with high mortality. Therapeutic plasma exchange (TPE) in the treatment of hypertriglyceridemic pancreatitis (HTGP) is a rapid and effective treatment modality. In this study, the results of TPE were evaluated and the frequency of lipoprotein lipase (LPL) mutation in these patients was determined.
Materials and methods
TPE was performed in 31 patients with HTGP at the Adult Therapeutic Apheresis Center.
Results
A TG level under 500 mg/dL was achieved by applying apheresis at a median of 2 times (IQR 2–2, min 1, max 6) in the 31 cases. LPL mutation was detected in 8 (25.8%) of the 31 hypertriglyceridemia cases. When TG levels before and after TPE were evaluated, the mean TG level before TPE was significantly higher (3132 ± 1472 mg/dL) than the mean TG level afterwards (948 ± 465 mg/dL, P < 0.001). This result represented a decrease of 69.7% TG after TPE.
Conclusion
TPE is a safe, fast, and effective treatment modality in experienced centers.
Collapse